Esmolol
Back to searchMolecule Structure
Scientific Name
Esmolol
Description of the Drug
Esmolol is a cardioselective beta-adrenergic blocker used for the short-term control of ventricular rate and heart rate in various types of tachycardia, including perioperative tachycardia and hypertension.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00187
http://www.drugbank.ca/drugs/DB00187
Brand Name(s)
Not Available
Company Owner(s)
Fresenius Kabi Usa Llc, Mylan Laboratories Ltd, Sagent Pharmaceuticals Inc, Hq Specialty Pharma Corp, Gland Pharma Ltd, American Regent Inc, Eugia Pharma Specialities Ltd, Baxter Healthcare Corp Anesthesia Critical Care, Hikma Pharmaceuticals Usa Inc, Mylan Institutional Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Beta-1 adrenergic receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL213 |
| Beta-2 adrenergic receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL3605 | ||
| PharmGKB | PA449500 | ||
| Human Metabolome Database | HMDB0014333 | ||
| DrugBank | DB00187 | ||
| PubChem: Thomson Pharma | 14825011 | ||
| PubChem | 59768 | ||
| LINCS | LSM-4957 | ||
| Nikkaji | J32.840E | ||
| BindingDB | 50404796 | ||
| EPA CompTox Dashboard | DTXSID4022995 | ||
| DrugCentral | 1054 | ||
| Brenda | 217392 | ||
| ChemicalBook | CB3454934 | CB6454935 | |
| Guide to Pharmacology | 7178 | ||
| rxnorm | BREVIBLOC | ESMOLOL HYDROCHLORIDE | ESMOLOL |
| KEGG Ligand | C06980 | ||
| ChEBI | 88206 |
